The Claim

In obese mice, administration of G49 causes a transient increase in hepatic lipid accumulation within 6 hours, characterized by elevated liver triglyceride levels and upregulated expression of the lipogenic genes Srebf1 and Fasn, mediated by glucagon receptor-induced lipolysis followed by insulin secretion.

Source: The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
66score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In obese mice, a compound called G49 leads to a temporary buildup of fat in the liver within six hours, accompanied by increased activity of genes involved in fat production, triggered by hormonal signals from glucagon and insulin.

See the scientific wording

In obese mice, G49 induces a transient hepatic lipid overload within 6 hours of administration, characterized by increased liver triglycerides and expression of lipogenic genes Srebf1 and Fasn, which is driven by glucagon receptor-mediated lipolysis and subsequent insulin secretion.

Why this might work

A drug called G49 tricks fat cells into releasing stored fat into the blood. The liver takes up this fat and temporarily stores it as oil, while also turning on genes that make even more fat. This happens because the fat release triggers the pancreas to release insulin, which tells the liver to make more fat. The whole process lasts only a few hours before the liver starts burning off the excess.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

    G49 is a drug that tricks the body into thinking it’s had surgery — it makes fat cells release fat, which goes to the liver and causes a temporary fat buildup, while also turning on genes that make more fat. This happens because of signals from glucagon and insulin.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.